George A. Samuel III

Insider Reports History

Entity
Individual
Location
C/O Lineage Cell Therapeutics, Inc., 2173 Salk Avenue, Suite 200, Carlsbad, CA
Signature
/s/ George A. Samuel III
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George A. Samuel III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lineage Cell Therapeutics, Inc. General Counsel and Secretary Common Shares 25.8K $16.8K $0.65 Feb 11, 2025 Direct
Lineage Cell Therapeutics, Inc. General Counsel and Secretary Employee Stock Option (Right to Buy) 750K Mar 10, 2025 Direct
Lineage Cell Therapeutics, Inc. General Counsel and Secretary Restricted Stock Units 6.08K Feb 11, 2025 Direct

Insider Reports Filed by George A. Samuel III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LCTX Lineage Cell Therapeutics, Inc. Mar 10, 2025 1 $0 4 Mar 12, 2025 General Counsel and Secretary
LCTX Lineage Cell Therapeutics, Inc. Feb 11, 2025 3 -$1.59K 4 Feb 12, 2025 General Counsel
LCTX Lineage Cell Therapeutics, Inc. Nov 26, 2024 1 $9K 4 Nov 26, 2024 General Counsel
LCTX Lineage Cell Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 8, 2024 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Feb 11, 2024 3 -$2.69K 4 Feb 12, 2024 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 10, 2023 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Feb 11, 2023 3 -$3.35K 4 Feb 14, 2023 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Mar 10, 2022 1 $0 4 Mar 11, 2022 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Sep 1, 2021 1 $0 4 Sep 2, 2021 General Counsel/Secretary
LCTX Lineage Cell Therapeutics, Inc. Sep 1, 2021 0 $0 3 Sep 2, 2021 General Counsel/Secretary